Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI tool automates liver tumor detection and monitoring

2.

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

3.

Year in Review: Multiple Myeloma

4.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

5.

Breast Cancer Incidence Rises in Asian American Women


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot